Scarlatti, G., Alcami, J., Bongertz, V., Fenyö, E., Heath, A., Heyndrickx, L., … Wrin, T. (2009). P04-18. Comparison of HIV neutralization assays for use in vaccine research and clinical trials, phase II: Results from the NeutNet working group. In Retrovirology (Vol. 6, p. P46). https://doi.org/10.1186/1742-4690-6-S3-P46

Scarlatti, G., J. Alcami, V. Bongertz, E. Fenyö, A. Heath, L. Heyndrickx, H. Holmes, et al. “P04-18. Comparison of HIV neutralization assays for use in vaccine research and clinical trials, phase II: Results from the NeutNet working group.” In Retrovirology, 6:P46, 2009. https://doi.org/10.1186/1742-4690-6-S3-P46.

Scarlatti G, Alcami J, Bongertz V, Fenyö E, Heath A, Heyndrickx L, et al. P04-18. Comparison of HIV neutralization assays for use in vaccine research and clinical trials, phase II: Results from the NeutNet working group. In: Retrovirology. 2009. p. P46.

Scarlatti, G., et al. “P04-18. Comparison of HIV neutralization assays for use in vaccine research and clinical trials, phase II: Results from the NeutNet working group.” Retrovirology, vol. 6, no. SUPPL. 3, 2009, p. P46. Scopus, doi:10.1186/1742-4690-6-S3-P46.

Scarlatti G, Alcami J, Bongertz V, Fenyö E, Heath A, Heyndrickx L, Holmes H, Jansson M, Lopalco L, Malnati M, Montefiori D, Moog C, Morris L, Osmanov S, Polonis V, Ramaswamy M, Sattentau Q, Schuitemaker H, Wrin T. P04-18. Comparison of HIV neutralization assays for use in vaccine research and clinical trials, phase II: Results from the NeutNet working group. Retrovirology. 2009. p. P46.